Ixaka Limited (09427131): administration
- Status
- Administration ended
- Administration began
- 2023-08-02
- Administrators
- Mark Guy Boughey, Michael Ian Field
- Administrators' firm
- Mazars
- Formerly
- Rexgenero Limited
- Incorporated
- 2015-02-06
- Location
- Bristol
- Industry
- 86220 Specialists medical practice activities
Why it went into administration
- Funding withdrawn / unable to refinance
- Regulatory change or action
- Loss of key people
From the administrators' statement
The Company was formed in February 2015 as Rexgenero Limited. In January 2021 it was renamed to Ixaka Limited.
At the date of Administration the Company had four directors and four employees who operated remotely, and had the use of rented premises in central London.
The Company is a biotech business with the underline objective to cure disease through cell and gene therapy. The Company raised/managed funding for the group and carried out ‘head office’ functions, with the clinical trials being executed through its subsidiaries in Spain and France with the intention of selling the research data and trials information to the pharmaceutical industry at a point in the future.
Administrators' statement of proposals (2023-09-19) · Companies House register